Vivani Medical (VANI) Other Non-Current Assets (2014 - 2026)
Vivani Medical (VANI) posted quarterly Other Non-Current Assets of $1.3 million for Q1 2026, up 913.64% year-over-year from $132000.0 in Q1 2025, and up 2687.5% quarter-over-quarter from $48000.0 in Q4 2025.
Vivani Medical (VANI) Other Non-Current Assets (2014 - 2026) Analysis & Trends
Vivani Medical's Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 913.64% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (up 913.64% YoY), while the FY2025 annual figure was $48000.0, down 96.41% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $1.3 million, up from $48000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $1.4 million in Q2 2023, with the low at $17000.0 in Q2 2022.
- The 5-year median for Other Non-Current Assets is $259000.0 (2022), against an average of $555705.9.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets jumped 7935.29% in 2023, then tumbled 96.41% in 2025.
- Vivani Medical's Other Non-Current Assets stood at $275000.0 in 2022, then surged by 386.55% to $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024, then sank by 96.41% to $48000.0 in 2025, then jumped by 2687.5% to $1.3 million in 2026.
- Business Quant data shows VANI's Other Non-Current Assets at $1.3 million in Q1 2026, $48000.0 in Q4 2025, and $23000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | 900,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 900,000.00 |
| Mar 31, 2026 | 1.34 Mn |
| Dec 31, 2025 | 48,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 129,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 87,000.00 |
| Jun 30, 2023 | 1.37 Mn |
| Mar 31, 2023 | 271,000.00 |
| Dec 31, 2022 | 275,000.00 |
| Sep 30, 2022 | 259,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 22,000.00 |